Confirmed Exhibitors
Menu
WTC 2025 Exhibitors
WTC 2025 Congress offers a unique opportunity to market to an international multidisciplinary event of researchers, clinicians, health professionals and patient advocates in the field of research and management.
WTC 2025 Organizing Committee would like to thank all our exhibitors for their support:
As the oldest and largest, independent kidney patient organization in the U.S. AAKP is dedicated to improving the lives and long-term outcomes of kidney patients through education, advocacy, patient engagement, and the fostering of patient communities. AAKP fights for early disease detection and the appropriate diagnosis of rare/genetic conditions.
Pleximark blood test measures the likelihood of acute cellular rejection by measuring whether recipient lymphocytes called T-cytotoxic memory cells show increased anti-donor activity
PlexCMV measures the level of cellular immunity to Cytomegalovirus (CMV) to help formulate personalized antiviral therapy or immunosuppressive treatment.
Establishing the level of anti-EBV immunity at baseline and during periods of high dose immunosuppression permits the level of anti-EBV immunity to be assessed in each patient allowing for adequate treatment planification.
The American Board for Transplant Certification (ABTC®) promotes education, competency, and professional growth in organ transplantation through exclusive, specialty certifications. ABTC certification programs include Certified Clinical Transplant Coordinator (CCTC®) Certified Clinical Transplant Nurse (CCTN®) Certified Procurement Transplant Coordinator (CPTC®) Certified Transplant Preservationist (CTP®) and Certified Transplant Financial Coordinator (CTFC).
At Apellis, we combine courageous science and compassion to develop life-changing medicines for some of the most challenging diseases patients face. Our goal is to transform treatment for a broad range of debilitating diseases by controlling a part of the immune system known as the complement cascade. We ushered in the first new class of complement medicine in 15 years, and now have two approved medicines targeting C3, the central protein in the cascade. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. With nearly a dozen clinical and pre-clinical programs underway, we believe we have only begun to unlock the potential of targeting C3 across many serious diseases.
Bridge to Life Ltd is a market leader in organ preservation solutions, offering premier products such as Belzer UW®, EasiSlush® and the VitaSmart Hypothermic Oxygenated Perfusion System. With a strong focus on product quality, innovation and accessibility, the company serves and partners with leading Transplant Centers and Organ Procurement Offices globally.
See the Visible Difference® with Designs for Vision’s exclusive wearable fluorescence wound imaging solution: REVEAL FC. Designs for Vision has been innovating wearable visual enhancement solutions for clinicians since 1961. Visit our booth to see our many magnification and illumination solutions including our patented Panoramic Loupes. Panoramic Loupes provide unprecedented field of view (100% wider than Prismatic Loupes). The LED DayLite° HDi headlights utilize exclusive optical designs that provide 45% brighter illumination with even distribution.
GEISTER MEDIZINTECHNIK GMBH - founded in 1984 - is a manufacturer and system supplier of surgical instruments for conventional open and minimal invasive (keyhole) surgery with a focus on cardiovascular, neuro-, joint and powered surgery. Located in Tuttlingen in Southwest Germany - the famous capital of the surgical industry worldwide. We are dedicated to servicing and supplying the surgical world with the highest quality instruments according to the specific requirements and helping medical professionals with their patient care in every part of the world.
From its formation in 2015, GTS has focused on improving the quality of preservation solutions, worldwide, by partnering with a 100 year+, FDA, EU, and Health Canada certified sterile solution manufacturer, SALF, of Bergamo, Italy. GTS and SALF work together relentlessly to improve the useability, storage, and overall quality of every solution produced at SALF. One example; GTS has researched methods of shipping/storage, which resulted in the first, 100% recyclable shipping container system for preservation solutions delivered to the Global organ procurement community. This focus on “Total Quality” turned out to be very fortuitous, in that since GTS’s first FDA clearance in the US (Servator H – HTK in 2017), several other suppliers of organ preservation solutions have had their products, FDA/EU withdrawn due to contamination and other quality issues.
IGL specializes in medical technology for donor organ and tissue preservation. Founded by Georges Antoine Lopez, inspired by his father's transplants, IGL is devoted to creating safe, innovative solutions that ensure transplantation success and enhance patient quality of life. Decades of research and expertise define IGL's trusted reputation.
IGL specializes in medical technology for donor organ and tissue preservation. Founded by Georges Antoine Lopez, inspired by his father's transplants, IGL is devoted to creating safe, innovative solutions that ensure transplantation success and enhance patient quality of life. Decades of research and expertise define IGL's trusted reputation.
Melinta Therapeutics provides innovative therapies to people impacted by acute and life-threatening illnesses. With an unsurpassed commitment to providers and the patients they serve, we work to ensure that all people who need our therapies can receive them. At Melinta, we’re visionaries dedicated to innovation while staying grounded in what matters most: patients.
From the success of LifePort Kidney Transporter, Organ Recovery Systems introduces the next generation of preservation with the upcoming launch of the LifePort Liver Transporter. In addition to providing innovative products, ORS delivers support via the LifePort mobile app, 24/7 Perfusion Helpline, Instructor-Led Training, and online Client Community.
Paragonix Technologies is a leading developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to preservation that represents a significant improvement over the traditional standard of care.
Paragonix Advanced Organ Preservation devices combine clinically-proven, stable cooling techniques with digital tracking and monitoring technologies to provide clinicians complete control and oversight throughout the donor organ journey. The clinical impact of Paragonix preservation technology is reinforced by the GUARDIAN clinical registries, the largest database of organ preservation data in the world that analyzes post-transplant outcomes in transplant recipients.
Pleximmune measures the risk of acute cellular rejection after liver or intestine transplantation in children and young adults less than 21 years of age. FDA-approved blood test
Pleximark blood test measures the likelihood of acute cellular rejection by measuring whether recipient lymphocytes called T-cytotoxic memory cells show increased anti-donor activity
PlexCMV measures the level of cellular immunity to Cytomegalovirus (CMV) to help formulate personalized antiviral therapy or immunosuppressive treatment.
Establishing the level of anti-EBV immunity at baseline and during periods of high dose immunosuppression permits the level of anti-EBV immunity to be assessed in each patient allowing for adequate treatment planification.
ProCure On-Demand offers the transplant community the highest quality organ recovery services in a reliable, flexible model with favorable pricing. ProCure offers an improved model for engaging more best-in-class surgeons and clinicians in the organ recovery process, flexibility to choose when and how you need support, optimized logistical strategies and transportation solutions that save time and money.